Background: Cochlear implantation (CI) is a safe and effective procedure for management of severe-profound hearing loss. Complications are uncommon, but when present, should be identified and managed appropriately. The CI and its habilitation services were halted during this time period. Through this article we have tried to showcase how our institute resumed the CI surgeries and managed its complications as well as how we tackled the problems faced in auditory habilitation of CI candidates. Methods: This was a retrospective review of the challenges in cochlear implantation and its complications during the COVID pandemic. A safe management plan was formulated. All patients were thoroughly evaluated and complications were classified as minor or major and were managed medically or surgically, based on its severity. Postoperative auditory habilitation challenges were also tackled with innovative approaches to habilitation. Results: A stringent protocol was followed during the pandemic. Wound infection, biofilm, device failure were the complications encountered. All challenges and complications were dealt with by an experienced CI surgeon appropriately with successful outcomes. Conclusions: During the pandemic, it was essential to deal with all the challenges in CI and its complications taking all necessary precautions. Complications of CI, although not common required prompt and effective management for optimal outcomes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.